Zhang., et al. showed, in mouse model of colon cancer, that anti-CSF1R treatment preferentially depleted a fraction of the C1QC+ TAM subset, while sparing SPP1+ TAM (166). This evidence concerns the gene SPP1 and colonic neoplasm.